Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-Atrolactic acid is a small molecule organic compound belonging to the class of benzene and substituted derivatives. It is an aromatic compound with the chemical formula C9H10O3. The compound is also known as (S)-(+)-Atrolactic acid or (S)-2-hydroxy-2-phenylpropanoic acid. It exists as a solid at room temperature and has predicted water solubility of 19.7 mg/mL and logP values around 1.07–1.33[1][6]. Its mechanism of action in biological systems is not well characterized in available literature; it appears to be primarily used in research rather than clinical applications[1]. There are no widely recognized therapeutic indications or approved uses for this compound at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (s)-atrolactic acid.